This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Nipah Virus Fusion Protein Site I Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for nipah virus fusion protein site I. It is affinity purified by protein A. It can be applied to IP of nipah virus fusion protein site I.
Specifications
Target Information
The nipah virus fusion protein F2 chain, also known as the F protein, contains a specific cleavage site known as site I, which is crucial for its activation and function. This site is recognized and cleaved by host cell proteases, leading to the separation of the F0 precursor into two disulfide-linked subunits, F1 and F2. The cleavage at site I is a critical step in the maturation of the F protein, enabling it to mediate the fusion of the viral envelope with the host cell membrane. Site I is a potential target for antiviral intervention because its disruption could prevent the F protein from undergoing the necessary cleavage to become active. Inhibiting the cleavage at this site could impair the virus's ability to fuse with host cells, thereby blocking viral entry and infection. The development of small molecule inhibitors or monoclonal antibodies that target site I could provide a novel therapeutic approach to combat nipah virus infections.
Shipping and Storage
This product is shipped at ambient temperature. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Diederich, Sandra, et al. "The nipah virus fusion protein is cleaved within the endosomal compartment." Journal of Biological Chemistry 280.33 (2005): 29899-29903.